Latest News in Pharma industry

2 days ago

In Bold Respiratory Play, Merck Bets $10 Billion on Verona's Revolutionary COPD Treatment

3 days ago

Centivax Raises $45M Series A to Advance Universal Flu Vaccine to Human Trials

5 days ago

Proxy Giants Hand Sinovac's Board Lifeline as $10 Billion Battle Reaches Breaking Point

12 days ago

Pharmaceutical Reshoring Continues - Hikma's $1 Billion Bet on American Medicine

14 days ago

A Breakthrough in the Storm - FDA Approves First Treatment for Deadly Inflammatory Condition

15 days ago

Breaking Ground in Addiction Medicine - Achieve Life Sciences' FDA Application Signals First New Smoking Cessation Drug in Two Decades

17 days ago

Pancreatic Cancer Drug Market Set for Threefold Surge as Innovation Pipeline Swells

17 days ago

Actuate Therapeutics Drug Extends Pancreatic Cancer Survival by 4 Months in Phase 2 Trial

18 days ago

Novo Nordisk Terminates Hims & Hers Deal Amid Weight-Loss Drug Compounding Controversy

19 days ago

Eli Lilly's Weekly Insulin Matches Daily Treatments in Major Clinical Trials

19 days ago

Novo Nordisk's Higher-Dose Wegovy Delivers 21% Weight Loss in Phase 3 Trial, Matching Surgical Results

19 days ago

Exelixis Drug Combination Extends Survival in Phase 3 Advanced Colorectal Cancer Trial

20 days ago

Novo Nordisk Advances Promising Weight Loss Drug Amycretin to Final Testing Stage After Strong Trial Results

24 days ago

FDA Grants Medicovestor's Pancreatic Cancer Drug Special Status as Treatment Shows Promise

26 days ago

AI Drug Discovery Firm Insilico Medicine Raises $110M and Reaches $1 Billion Valuation

26 days ago

Dupixent Outperforms Xolair in Groundbreaking EVEREST Trial for Nasal Polyps and Asthma Treatment

28 days ago

AstraZeneca Signs $5.3 Billion AI Drug Discovery Deal with Chinese Firm CSPC

29 days ago

FDA Approves Moderna's RSV Vaccine for Younger At-Risk Adults Aged 18-59

29 days ago

J&J's New Leukemia Drug Shows 90% Response Rate in Early Trials

30 days ago

FDA Approves Nuvation Bio's New Lung Cancer Drug IBTROZI With 90% Response Rate

30 days ago

Novo Nordisk Invests $812 Million in AI Drug Discovery Deal for New Obesity Treatment

33 days ago

Samsung Bioepis Partners with NIPRO to Bring Multiple Biosimilars to Japanese Market

35 days ago

Rare Kidney Disease Patients See Hope as EMPAVELI Maintains Strong Results After One Year

38 days ago

Roche's New Room-Temperature SMA Tablet Wins European Approval, Expanding Treatment Access

39 days ago

Bristol Myers Squibb Commits $11.1 Billion to Partner with BioNTech on Dual-Target Cancer Drug

40 days ago

AstraZeneca's IMFINZI Reduces Gastric Cancer Recurrence Risk by 29% in Landmark Trial

44 days ago

Biohaven's New Kidney Disease Drug Shows 81% Reduction in Key Disease Marker During Early Testing

45 days ago

Rocket Pharma Stock Plunges 62.8% After Patient Death Halts Gene Therapy Trial

45 days ago

Lilly's $1 Billion Bet on Pain - Acquisition Targets the Next Frontier in Non-Opioid Treatment

47 days ago

China's Mazdutide Weight Loss Drug Shows 15% Effectiveness in Major Medical Journal Study

47 days ago

SpringWorks' NF1 Drug Mirdametinib Wins European Regulator Support for Adults and Children

49 days ago

Countdown to Cash Crisis - The High-Stakes Proxy War at MediPharm Labs

49 days ago

FDA Warning on Allergy Drug Withdrawal Side Effects Shakes Pharmaceutical Market While Creating Investment Opportunities

51 days ago

Sanofi Acquires Alzheimer's Drug Developer Vigil Neuroscience for $600 Million to Advance Brain-Penetrating TREM2 Therapy

52 days ago

FDA Panel Backs First Treatment for High-Risk Smoldering Multiple Myeloma

53 days ago

Persist AI Raises $12M and Launches Cloud Lab Platform to Transform Pharmaceutical Formulation Speed

53 days ago

AstraZeneca's Breakthrough Asthma Treatment Challenges 50 Years of Standard Care

55 days ago

Novo Nordisk's Leadership Crisis - Strategic Implications of Jørgensen's Surprise Exit

57 days ago

Takeda's Narcolepsy Drug Shows Breakthrough Results in Restoring Normal Wakefulness for Patients

57 days ago

Pathos AI Raises $365 Million to Build Largest Multimodal Foundation Model for Cancer Drug Development

58 days ago

In a First for a Rare Cancer, Merck Secures FDA Nod for WELIREG — But Market Access and Safety Risks Loom Large

59 days ago

UnitedHealth Shares Plunge as Former CEO Hemsley Returns Following Witty's Abrupt Exit

65 days ago

Amgen Wins UK Approval for First Targeted Thyroid Eye Disease Treatment as Pressure Mounts from Cheaper Rivals

68 days ago

Early Trial Shows REC-4881 Reduces Polyp Burden by 43 Percent in Rare Genetic Cancer Disorder

69 days ago

Gene Therapy Market Shaken as Vertex Abandons AAV Technology Amid Safety Concerns and Regulatory Upheaval

70 days ago

Pykus Therapeutics' Novel Retinal Sealant Shows 91% Success Rate in Early Trials, Eliminating Need for Face-Down Recovery

72 days ago

Semaglutide Shows Strong Results in Major Liver Disease Trial, FDA Review Now Underway

73 days ago

Semaglutide Safety Concerns Mount as CDC Links Popular Weight Loss Drugs to Over 24,000 Emergency Room Visits

74 days ago

German Pharma Giant Merck Acquires SpringWorks for $3.9 Billion in Rare Disease Market Push

76 days ago

Pfizer's Sasanlimab-BCG Combination Shows 32% Reduction in Bladder Cancer Recurrence in Landmark Trial